Ken Griffin Bio Sig Technologies, Inc. Call Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$0.4 - $1.39 $18,760 - $65,190
-46,900 Reduced 68.97%
21,100 $10,000
Q2 2023

Aug 14, 2023
BUY
$1.07 - $1.55 $8,132 - $11,780
7,600 Added 12.58%
68,000 $85,000
Q1 2023

May 15, 2023
BUY
$0.42 - $1.4 $7,938 - $26,460
18,900 Added 45.54%
60,400 $68,000
Q4 2022

Feb 14, 2023
SELL
$0.31 - $8.8 $1,519 - $43,120
-4,900 Reduced 10.56%
41,500 $17,000
Q3 2022

Nov 14, 2022
BUY
$0.56 - $6.98 $560 - $6,980
1,000 Added 2.2%
46,400 $30,000

Others Institutions Holding BSGM

# of Institutions
4
Shares Held
88.2K
Call Options Held
0
Put Options Held
0
View Full List

About BioSig Technologies, Inc.

BSGM Quotes by TradingView
  • Ticker BSGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,814,400
  • Market Cap $13.4M
  • Description
  • BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...
More about BSGM
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email